BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29384218)

  • 1. microRNA-130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO-1.
    Chen X; Zhao M; Huang J; Li Y; Wang S; Harrington CA; Qian DZ; Sun XX; Dai MS
    J Cell Biochem; 2018 Jun; 119(6):4945-4956. PubMed ID: 29384218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stromal loss of miR-4516 promotes the FOSL1-dependent proliferation and malignancy of triple negative breast cancer.
    Kim JE; Kim BG; Jang Y; Kang S; Lee JH; Cho NH
    Cancer Lett; 2020 Jan; 469():256-265. PubMed ID: 31672492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3.
    Toda H; Kurozumi S; Kijima Y; Idichi T; Shinden Y; Yamada Y; Arai T; Maemura K; Fujii T; Horiguchi J; Natsugoe S; Seki N
    J Hum Genet; 2018 Dec; 63(12):1197-1210. PubMed ID: 30228364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer.
    Luo LJ; Yang F; Ding JJ; Yan DL; Wang DD; Yang SJ; Ding L; Li J; Chen D; Ma R; Wu JZ; Tang JH
    Gene; 2016 Dec; 594(1):47-58. PubMed ID: 27593563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-130a inhibits cell proliferation, invasion and migration in human breast cancer by targeting the RAB5A.
    Pan Y; Wang R; Zhang F; Chen Y; Lv Q; Long G; Yang K
    Int J Clin Exp Pathol; 2015; 8(1):384-93. PubMed ID: 25755726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of the microRNA-138-Fos-like antigen 1 (FOSL1) regulatory module in squamous cell carcinoma.
    Jin Y; Wang C; Liu X; Mu W; Chen Z; Yu D; Wang A; Dai Y; Zhou X
    J Biol Chem; 2011 Nov; 286(46):40104-9. PubMed ID: 21969367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer.
    Xiong H; Yan T; Zhang W; Shi F; Jiang X; Wang X; Li S; Chen Y; Chen C; Zhu Y
    Cell Signal; 2018 Apr; 44():33-42. PubMed ID: 29339084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
    Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-496 inhibits triple negative breast cancer cell proliferation by targeting Del-1.
    Lee SJ; Jeong JH; Lee J; Park HY; Jung JH; Kang J; Kim EA; Park NJ; Park JY; Lee IH; Chae YS
    Medicine (Baltimore); 2021 Apr; 100(14):e25270. PubMed ID: 33832090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells.
    Das SG; Romagnoli M; Mineva ND; Barillé-Nion S; Jézéquel P; Campone M; Sonenshein GE
    Breast Cancer Res; 2016 Apr; 18(1):40. PubMed ID: 27039296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
    Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
    Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10.
    Liu F; Zhuang L; Wu R; Li D
    J BUON; 2019; 24(5):1905-1912. PubMed ID: 31786854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-130a targeting hypoxia-inducible factor 1 alpha suppresses cell metastasis and Warburg effect of NSCLC cells under hypoxia.
    Shi J; Wang H; Feng W; Huang S; An J; Qiu Y; Wu K
    Life Sci; 2020 Aug; 255():117826. PubMed ID: 32450163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-1246 suppresses the metastasis of breast cancer cells by targeting the DYRK1A/PGRN axis to prevent the epithelial-mesenchymal transition.
    Wang P; Chen W; Zhang Y; Zhong Q; Li Z; Wang Y
    Mol Biol Rep; 2022 Apr; 49(4):2711-2721. PubMed ID: 35059968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor-κB-dependent microRNA-130a upregulation promotes cervical cancer cell growth by targeting phosphatase and tensin homolog.
    Feng Y; Zhou S; Li G; Hu C; Zou W; Zhang H; Sun L
    Arch Biochem Biophys; 2016 May; 598():57-65. PubMed ID: 27040383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of miRNAs Targeting mTOR and S6K1 Genes of mTOR Signaling Pathway Including miR-96, miR-557, and miR-3182 in Triple-Negative Breast Cancer.
    Razaviyan J; Hadavi R; Tavakoli R; Kamani F; Paknejad M; Mohammadi-Yeganeh S
    Appl Biochem Biotechnol; 2018 Dec; 186(4):1074-1089. PubMed ID: 29862445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.